Hepatocellular carcinoma (HCC) is one of the most deadly cancers. Aberrant oncogenic activation of the Wnt/b-catenin signaling pathway contributes to hepatocellular carcinogenesis. Various epigenetic modifications of the Wnt antagonist secreted frizzledrelated protein (SFRP) family have been implicated in regulating Wnt signaling. Here, we report that Hepatitis C virus (HCV) core protein downregulates SFRP1 expression when it is expressed in Huh7 and HepG2 cells. SFRP1 expression can be effectively restored by using either a DNA methylation inhibitor alone or in combination with a histone deacetylase inhibitor. DNA methylation analysis of the SFRP1 promoter revealed that cytosine-phosphate-guanine (CpG) islands close to the transcriptional start site (TSS) in the SFRP1 promoter were hypermethylated in core-expressing Huh7 cells, suggesting that HCV core protein may downregulate SFRP1 expression by inducing hypermethylation of the SFRP1 promoter. Chromatin immunoprecipitation revealed that HCV core protein markedly increased the expression level and binding of DNA methyltransferase-1 (Dnmt1) and histone deacetylase-1 (HDAC1) to the TSS of the SFRP1 promoter region, resulting in repression of acetyl-histone H3-binding capacity to SFRP1 promoter and the eventual epigenetic silencing of SFRP1 expression. Furthermore, the core protein-promoted cell proliferation, migration and invasiveness were effectively abrogated either by Dnmt1 knockdown or restoration of SFRP1 expression in hepatoma cells. Dnmt1 knockdown or SFRP1 overexpression also inhibited HCV core-induced epithelial-mesenchymal transition (EMT) and significantly decreased the expression levels of activated b-catenin and Wnt/b-catenin target genes, c-Myc and cyclin D1. We further showed that knockdown of Dnmt1 and restoration of SFRP1 inhibited core-induced in vivo tumor growth and aggressiveness in a xenograft HCC model. Taken together, our results strongly suggest that the HCV core-induced epigenetic silencing of SFRP1 may lead to the activation of the Wnt signaling pathway and thus contribute to HCC aggressiveness through induction of EMT.
INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common human cancers and a leading cause of cancer-related death. 1 One of the most important risk factors for developing HCC is chronic Hepatitis C virus (HCV) infection. 2 HCV infects approximately 170 million people worldwide, and a proportion of them develop cirrhosis and HCC. 3 However, the mechanisms underlying HCVassociated hepatocarcinogenesis are not fully understood.
As a structural component of HCV, the 21 kDa core protein has been strongly implicated in HCC pathogenesis by virtue of its role in transcriptional regulation of cellular proto-oncogenes through interaction with cytoplasmic proteins and signal transduction pathways. 4 HCV core protein has been reported to directly modulate hepatocyte proliferation and transformation by regulating important signaling pathways, 5 such as the Wnt/bcatenin signaling pathway.
Wnt/b-catenin signaling pathway controls many biological processes, including cell fate determination and cell proliferation. 6 In normal conditions, Wnt ligands bind to the frizzled and low-densitylipoprotein-related protein 5/6 co-receptor complex. This binding activates a canonical pathway that results in b-catenin accumulation and nuclear translocation, and subsequent activation of target genes such as c-Myc and cyclin D1. 7 Nuclear and/or cellular b-catenin accumulation has been reported in several human cancers. However, genetic mutations of b-catenin, adenomatous polyposis coli (APC) or Axin genes are observed only in a small fraction of cancer cases. 8 Mounting data suggest that regulatory mechanisms other than genetic mutations of Wnt signaling pathway have important roles in carcinogenesis. Epigenetic events of extracellular Wnt antagonists, such as secreted frizzled-related proteins (SFRPs), Wnt inhibitory factor 1 and Dickkopf (DKKs), may contribute to the abnormal activation of Wnt signaling pathway. 9 SFRPs have an N-terminal cysteine-rich domain that is homologous to frizzled proteins, which can hinder Wnt-receptor interactions and block Wnt signaling. 10 However, it remains unclear whether HCV-encoded viral proteins have a direct role in epigenetic regulation of Wnt antagonists. 1 The present study was designed to investigate whether the HCV core protein epigenetically regulates SFRP1 expression and hence determine whether it is involved in HCV-related HCC development. Our results found that HCV core protein triggers epigenetic silencing of SFRP1 gene. Chromatin immunoprecipitaion (ChIP) analysis in HCC cells showed an enhanced binding of Dnmt1, HDAC1 and methyl-CpG-binding domain (MBD) proteins on a proximal region near the transcriptional starting site (TSS) of the SFRP1 gene. Functional analysis showed that core protein promoted cell proliferation and migration, which was abrogated by either Dnmt1 knockdown or restoration of SFRP1 expression both in vitro and in vivo. Dnmt1 knockdown or SFRP1 re-expression inhibited HCV core-induced epithelialmesenchymal transition (EMT) and resulted in inactivation of Wnt/b-catenin signaling. Taken together, our data strongly suggest that HCV core protein may constitutively activate Wnt/ b-catenin signaling by inducing epigenetic repression of the Wnt antagonist SFRP1, leading to HCC carcinogenesis through induction of EMT.
RESULTS
Decreased SFRP1 in core-expressing HCC cell lines can be restored by 5-Aza-2 0 deoxycytidine (Aza) or trichostatin A (TSA)
We previously showed that HCV core protein suppressed the expression levels of Wnt antagonists, including SFRP3, SFRP5 and DKK1 in HCC cell lines. 11 To expand these studies to additional SFRP genes, we assessed the expression levels of all SFRP members from SFRP1 to SFRP5 in core-expressing cells (Supplementary Figure 1A) . Ectopic expression of HCV core in Huh7 or HepG2 cells mediated SFRP1, SFRP2 and SFRP5 transcriptional repression. Downregulation of SFRP1 was further confirmed by real-time PCR and western blotting (Figures 1a and e) . We also determined the protein levels of SFRP1 and Dnmt1 in an HCV replicon system. Core, NS3 and E1 proteins were readily detectable in JFH-1 RNAtransfected Huh7.5.1 cells (Supplementary Figure 1B) . As shown in Figure 1b , the expression of SFRP1 was dramatically inhibited, whereas Dnmt1 was markedly upregulated with the replication of HCV.
Since silencing of SFRP1 expression in HCC by aberrant methylation within its promoter region has been reported, 1 we next explored whether gene promoter hypermethylation was important for core-mediated SFRP1 repression. Core-expressing Huh7 cells were treated with Aza, an inhibitor of DNA methylation. As shown in Figures 1c-e, Aza restored SFRP1 transcripts and protein expression in a concentration-dependent manner, whereas the levels of Dnmt1 were decreased in response to Aza treatment. We further investigated if histone acetylation has any role in the regulation of SFRP1 expression. Accordingly, the extent of DNA hypermethylation in core-mediated SFRP1 repression was evaluated in the mouse hepatic progenitor cell HP14.5 cells, 12, 13 and in the SK-Hep1 hepatoma cell line upon exposure to the histone deacetylase inhibitor TSA. Consistent with the above results, Aza or TSA treatment effectively restored SFRP1 expression in core-expressing hepatoma cells. Moreover, a combined treatment with Aza and TSA caused moderate upregulation of SFRP1 expression to a greater extent than in cells treated with either agent alone (Figure 1f ), suggesting that histone deacetylation has a synergetic role in DNA methylation-mediated SFRP1 silencing. Epigenetic inactivation of SFRP1 is associated with its promoter hypermethylation SFRPs have been shown to be transcriptionally inactivated in cancer cells through CpG methylation. To determine whether downregulation of SFRP1 in core-expressing HCC cell lines is caused by promoter hypermethylation, we determined the methylation status of the SFRP1 promoter in core-expressing HCC lines. Methylation-specific PCR (MSP) analysis covering the region abundant in CpG islands (Figure 2a ) indicated that all three HCC lines had SFRP1 hypermethylation compared with control cells infected with adenovirus expressing green fluorescent protein (AdGFP) (Figure 2b) . Similar results of an SFRP1 hypermethylation signature were observed in Huh7-Core stable cells (Figure 2c ). DNA methylation status was further confirmed by bisulfite sequencing. The frequency of SFRP1 gene methylation in core-expressing Huh7 cells was 91.4%, significantly higher than that of control cells (68.5%, Po0.01; Figure 2e ). This effect was partially abolished by Aza treatment, which increased the extent of non-methylation at the SFRP1 promoter in Huh7 cells (Figures 2d and e) . A similar result was also obtained in HepG2 and LO2 cells (data not shown). Thus, our data strongly suggest that downregulation of SFRP1 in coreexpressing HCC cells may be caused by promoter hypermethylation. In order to determine whether HCV core could downregulate SFRP1 promoter activity, deletions constructs containing the 5 0 -flanking region of the SFRP1 gene were designed. The luciferase reporter assays of the constructs indicated that SFRP1 promoter activities were strongly suppressed by HCV core protein in a dose-dependent manner in both Huh7 and LO2 cells, whereas the AdGFP control had no effect on the SFRP1 promoter activity (Supplementary Figure 2) . These results suggest that ectopic expression of HCV core can suppress SFRP1 promoter activity in HCC cells.
Epigenetic repression of SFRP1 by HCV core is associated with DNA methylation and histone deacetylation To further determine molecular mechanisms through which HCV core regulates SFRP1 expression, we examined the expression levels of Dnmt1, Dnmt3a, Dnmt3b and HDAC1 in core-expressing Huh7 cells. Our results indicated that Dnmt1 and HDAC1 expression were markedly enhanced upon core expression. However, the expression of Dnmt3a and Dnmt3b showed no detectable change in core-expressing cells (Supplementary Figures 3A and B) . Likewise, the protein levels of Dnmt1 and HDAC1 were upregulated after ectopic expression of HCV core protein in SK-Hep1 cells (Supplementary Figure 3B) . These findings revealed that core-mediated repression of SFRP1 can be restored after Aza or TSA treatment, and that core may regulate the expression of Dnmt1 and HDAC1, suggesting that core may regulate SFRP1 expression through epigenetic modifications.
To test this hypothesis, we determined the levels of Dnmts and HDAC1 bound to the SFRP1 promoter region in core-expressing cells. We designed a panel of four primer pairs covering a 45 kb region surrounding the TSS of SFRP1 (Figure 3a ) and determined the presence of CpG methylation and histone acetylation marks. ChIP analyses revealed that abundant binding of Dnmt1 and HDAC1 were detected 400 bp upstream and 500 bp downstream of the TSS of SFRP1 in core-expressing cells. In contrast, core inhibited the binding of P300 and acetylated histone H3 to the SFRP1 promoter ( Figure 3b ). Meanwhile, no epigenetic difference was detected in the distant upstream region of SFRP1, suggesting that a core-induced epigenetic signature is primarily involved in the proximal region of the TSS of SFRP1. ChIPquantitative PCR assays further confirmed the enhanced binding of Dnmt1 (five-to sixfold higher than the control) and HDAC1 (approximately fourfold higher) to the SFRP1 promoter region (Figure 3d ). MBD proteins (MeCP2, MBD1, MBD2) are interpreters 14 Therefore, we investigated whether MBD proteins were involved in epigenetic silencing of SFRP1. We found that core enhanced the binding of MBD1, MBD2 and MeCP2 to the SFRP1 promoter region (Figure 3c ). To further confirm that epigenetic silencing of SFRP1 was mainly induced by DNA methylation and histone deacetylation, core-expressing cells were exposed to Aza or TSA and the binding capacity of Dnmt1 and HDAC1 on SFRP1 promoter was measured by ChIP analysis. We found that the Dnmt1 associated with SFRP1 promoter was completely dissociated after Aza treatment. However, only a slightly reduction of HDAC1 binding was observed in the TSA treatment group (Figure 3e) . Similar results of enriched binding of DNA methylation and histone deacetylation were observed in core-expressing SK-Hep1 cells (Supplementary Figure 3C) . Moreover, Dnmt1 associated with SFRP1 promoter was partially dissociated after Aza treatment (Supplementary Figure 3D) . Furthermore, the physical interactions between core protein and Dnmt1 or HDAC1 were investigated by coimmunoprecipitation assay in our study. We found that core protein could not directly interact with either Dnmt1 or HDAC1 complexes (Supplementary Figure 4) . Thus, these results strongly suggest that SFRP1 may be downregulated by HCV core through the enhanced binding of Dnmt1, MBD proteins and HDAC1 onto its promoter region and DNA methylation may have a dominant role.
Either knockdown of Dnmt1 or overexpression of SFRP1 downregulates Wnt/b-catenin target genes and decreases EMT induced by HCV core The above data indicated that HCV core may induce epigenetic silencing of SFRP1 mainly through DNA methylation. To determine the relationship between silencing of Dnmt1 expression and Wnt signaling in core-expressing HCC cells, the b-catenin status in Huh7-Core and LO2-Core cells was assessed. First, the enforced restoration of SFRP1 or silencing of Dnmt1 by adenoviruses transduction was confirmed in Huh7-Core cells (Figures 4a and b) . Knockdown of Dnmt1 or re-expression of SFRP1 caused a significant decrease in the level of activated b-catenin in Huh7-Core (Figure 4c ) and LO2-Core cells (data not shown). Likewise, Wnt target genes c-Myc and cyclin D1 were markedly downregulated after Dnmt1 silencing or SFRP1 restoration in Huh7-Core cells (Figure 4c) . Interestingly, the protein levels of SFRP1 in the same lines showed higher expression after the treatment of siDnmt1 (Figure 4b ). Whereas in core-expressing Huh7 cells, overexpression of SFRP1 decreased Dnmt1 expression (Figure 4a ).
EMT is a key event in tumor invasion whereby epithelial cell layers lose cell-cell contacts by activation of several signaling pathways including Wnt/b-catenin. 15 Loss of E-cadherin is considered as a major event in EMT; thus, we evaluated E-cadherin expression in the core-expressing HCC cells. As shown in Figure 4d , the core-expressing Huh7 cells had a marked decrease in E-cadherin that was restored by knockdown of Dnmt1 or overexpression of SFRP1. Conversely, the expression levels of mesenchymal markers b-catenin, fibronectin and twist were upregulated by core and reduced after transduced with adenovirus expressing SFRP1 (AdSFRP1) or shRNA targeting Dnmt1 (AdsiDnmt1) (Figure 4d ). These data indicated that knockdown of Dnmt1 and overexpression of SFRP1 effectively prevented Wnt/b-catenin activation and blocked EMT process induced by HCV core protein in HCC lines.
Knockdown of Dnmt1 or restoration of SFRP1 suppresses proliferation and migration of HCC cell lines SFRP1 has been shown to hinder Wnt ligand and receptor binding, leading to the blockade of the Wnt signaling pathway and tumorigenesis. 10 Moreover, our findings suggested that HCV core can trigger epigenetic silencing of SFRP1 by upregulation of Dnmt1. Therefore, we studied the effects of Dnmt1 silencing or SFRP1 restoration on cell proliferation and migration of HCC cells. Cell proliferation and colony formation ability of Huh7 or SK-Hep1 cells stably transduced with core (Supplementary Figure 1C) were shown to increase markedly when compared with the parental cell line (Figures 5a-c and Supplementary Figures 5A-C) . However, there was a significant decrease in the rate of cell proliferation when coreexpressing HCC cells were transduced with AdsiDnmt1 or AdSFRP1 (Figures 5b and c and Supplementary Figures 5B and C) .
As cell migration and invasiveness are important indicators of metastatic potential, we investigated migration and invasiveness of Huh7 clones expressing HCV core protein by using Transwell migration assays and Matrigel invasion assays. In cell migration assay, the average number of HCV-Core stable clones migrating through the Transwell membrane was significantly higher than that of the control cells (Po0.01; Figure 5d ). Likewise, in the invasion assay, Huh7-Core cells invading through the Matrigel were more than in parental cells (Figure 5e Figures 6A and D) . When cells were stably transduced with HCV core, tumor growth rate was enhanced markedly, compared with that of Huh7 cells (Figures 6A and B) . We also found that tumor growth, Dnmt1 and HDAC activities were inhibited by the knockdown of Dnmt1 and restoration of SFRP1 (Figures 6A and B; Supplementary Figures 6B and C) . We further assessed the levels of cell proliferation markers in the tumor samples retrieved from mice and found that proliferating cell nuclear antigen (PCNA) expression significantly accumulated in the nucleus of coreexpressing cells, but was almost undetectable in AdsiDnmt1-or AdSFRP1-infected cells ( Figure 6C (a-e) ). Accordingly, the enforced expression of SFRP1 or knockdown of Dnmt1 significantly decreased the cellular accumulation of b-catenin ( Figure 6C (f-j) ), the expression of Wnt target gene (c-Myc; Figure 6C (p-t) ). As the downstream targets of Wnt/b-catenin pathway, VEGF, MMP-2 and MMP-9 are principal regulators of tumor progression and metastasis. 16, 17 Next, we measured VEGF, MMP-2 and MMP-9 expression in the xenograft tissues. Consistent with the decreased cellular accumulation of b-catenin, overexpression of SFRP1 or silencing of Dnmt1 also repressed the expression of VEGF, MMP-2 and MMP-9 (Supplementary Figure 6D (a-o) ). Taken together, 
DISCUSSION
SFRP1 is an extracellular signaling molecule that antagonizes Wnt signaling and has a key role in the development of various cancers, including HCC. 18, 19 Previous studies have shown that SFRP1 is frequently hypermethylated in several cancers and that its downregulation is associated with methylation-mediated gene silencing. 20, 21 However, it is not clear if HCV core protein is involved in epigenetic modification of SFRP1 during HCC carcinogenesis. Here, we provide strong evidence that HCV core may induce epigenetic silencing of SFRP1, which leads to the activation of the Wnt signaling pathway and thus contributes to HCC carcinogenesis. DNA methylation in mammalian cells is catalyzed by Dnmt1, 3a and 3b enzymes, which use S-adenosyl methionine as the methyl donor, 22 and overexpression of these enzymes are associated with promoter hypermethylation of tumor-suppressor genes in various human cancers. 23 Dnmt1 has been shown to modulate the expression of tumor-suppressor genes via epigenetic modification of E-cadherin, 24 PARP-1 25 and GSTP1. 26 Consistent with the role of Dnmts in HCV-related carcinogenesis, 5, 27 our work indicated that Dnmt1, but not Dnmt3a or Dnmt3b, was increased in coreexpressing cells suggesting that the core protein could indirectly promote tumor progression. It is interesting that enforced overexpression of SFRP1 could moderately downregulate Dnmt1 protein expression, whereas knockdown of Dnmt1 will markedly restored SFRP1 expression. One explanation is that constitutive Wnt/ b-catenin signaling may result from the increased production of Dnmt1. 28, 29 The APC/b-catenin/T cell factor (TCF) pathway has been shown to upregulate Dnmt1 expression. 30 Although the promoter Epigenetic alterations in gene expression are mainly due to DNA methylation status and histone acetylation. In our study, we found that a SFRP1 promoter has a high density of methylated CpGs in core-expressing cells. In addition, the epigenetic signatures in this region include higher occupancy of MBD1, MBD2 and MeCP2 with concomitant decreased enrichment of AcH3 and P300. Based on these findings, we propose a working model, in which the epigenetic silencing of SFRP1 in hepatocytes is induced by HCV core via DNA methylation and histone deacetylation (Figure 7 ), leading to specific downregulation of SFRP1 transcription.
Recent evidence expands on the importance of cooperation and interaction between chromatin modification and DNA methylation states. 35 Dnmts have been reported to form complexes with other chromatin-modifying proteins such as HDAC1 and HDAC2. 36, 37 Meanwhile, the commonly used HDAC inhibitor TSA also triggered DNA dehydroxymethylation. 38 Our results are consistent with these reports as we found that Dnmt1 and HDAC increase histone deacetylation and facilitate DNA methylation. Furthermore, the recruiting ability of MBD proteins to HDACs provides a molecular mechanism for this interaction.
EMT is a well-characterized process whereby epithelial cells lose their epithelial characteristics and acquire a mesenchymal phenotype. In this study, HCV core was shown to suppress E-cadherin expression with concomitant upregulation of representative mesenchymal markers, that is, fibronectin and twist, contributing to the decreased cell adhesion and enhanced tumor metastasis. These findings are consistent with earlier studies in which the HCC-derived core protein or NS5A protein of HCV may promote EMT, implicating the pathogenic roles of viral proteins in oncogenesis, especially the tumorigenic role of chronic HCV infection in HCC. [39] [40] [41] Restoration of SFRP1 has been shown to downregulate cisplatin-based chemoresistance of HCC, possibly through modifying the EMT process. In fact, methylation of SFRP5 correlates with the chemoresistance of ovarian cancer. 42 Thus, it would be interesting to investigate the potential role of epigenetic silencing of SFRP1 by HCV core in chemosensitivity of HCC.
In summary, our findings suggest that HCV core can trigger epigenetic silencing of SFRP1, resulting in increased proliferation, migration and invasion ability of hepatoma cells in vitro and tumorigenicity in vivo. These changes, together with the coreinduced decrease in E-cadherin and enhanced expression of fibronectin, twist and b-catenin, are consistent with transition from an epithelial to a mesenchymal phenotype and may contribute to HCC carcinogenesis. Thus, our study underscores the importance of HCV core-induced EMT and activation of the Wnt/b-catenin pathway in liver cancer development.
MATERIALS AND METHODS

Cell lines and recombinant adenoviruses
Human HCC cell lines SK-Hep1, HepG2 and Huh7 2 were cultured with Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Mouse hepatic progenitor cell line HP14.5 was cultured as previously described. 12, 13 Adenovirus expressing HCV core, namely AdCore, was generated previously using the AdEasy system. 11 Adenoviruses expressing SFRP1, Dnmt1 inhibitor siDnmt1 and scrambled shRNA control (AdsiControl) were kindly provided by Dr T-C He of University of Chicago, USA. In addition to the expression of transgenes, AdsiDnmt1, AdsiControl and AdSFRP1 also express red fluorescent protein (RFP) as a marker for monitoring infection efficiency. An analogous adenovirus expressing only RFP (AdRFP) was used as a control. 43 HCV infection HCV full-length replicon JFH-1 (genotype 2a), which replicates efficiently and produce virus particle (HCVcc) in Huh7.5.1, 44 was linearized with XBaI (Takara, Dalian, China), and used as template for in vitro RNA transcription using a MEGAscript Kit (Ambion Inc., Austin, TX, USA) according to the manufacture's protocol. RNA was cleaned up by precipitation with lithium chloride. Huh7.5.1 cells were subsequently transfected with 10 mg of the synthesized HCV RNA, and the protein levels of HCV core, NS3 and E1 were detected when an obvious cytopathic effect was observed.
Antibodies
The following antibodies were used in this study: HCV core 
RNA isolation and quantitative reverse transcription-PCR analysis
Total RNA was extracted and quantitative reverse transcription-PCR analysis was performed as described.
11 SYBR Green-based quantitative PCR analysis was carried out using the DNA Engine Opticon 2 real-time PCR detection system (Bio-Rad, Berkeley, CA, USA).
Aza and TSA treatment
Human hepatoma cell lines or mouse hepatic progenitor cells HP 14.5 were seeded at 10% confluence. At 16 h after plating, the normal culture media was replaced with the growth media containing the indicated concentration of Aza or TSA. Cell culture medium was replaced with freshly added Aza or TSA for every 24 h and the total incubation time was 96 h. The combined treatment of Aza and TSA was performed by incubating cells with TSA for 48 h followed by a 48 h exposure to Aza. The genomic DNA, total protein and total RNA were extracted from cells before and after Aza or TSA treatment and used for MSP, western blotting and reverse transcription-PCR.
DNA methylation analysis DNA methylation status was determined by MSP and bisulfite genomic sequencing. The genomic DNA was extracted from Huh7 cells and treated with EZ DNA methylation kit (Zymo Research, Orange, CA, USA). Then, 800 ng of bisulfite-treated genomic DNA were used as samples in MSP and bisulfite genomic sequencing analysis. PCR primers and reaction conditions were described in Supplementary Table 1. Amplified PCR product was cloned into pMD-19 vector (Takara). At least 10 separate clones were chosen for sequence analysis (Invitrogen Co., Shanghai, China).
ChIP analysis
ChIP was carried out as described previously. 43 Briefly, 5 Â 10 6 cells were used for each ChIP assay, and each assay condition was done in duplicate. Subconfluent Huh7 cells were infected with adenovirus expressing HCV core (AdCore) or adenovirus expressing green fluorescent protein (AdGFP) for 36 h. Sonicated cell lysates were subjected to immunoprecipitation using 5 mg of respective primary antibody (normal IgG served as control). Following elution, DNA was extracted with phenol/chloroform, ethanol precipitated and resuspended in ddH 2 O for PCR analysis. Four pairs of primers specific for human SFRP1 promoter were used for PCR amplification (Supplementary Table 1 ). For ChIP-quantitative PCR, the immunoprecipitated DNA was quantified by real-time PCR using the DNA Engine Opticon 2 real-time PCR detection system (Bio-Rad). The enrichment of epigenetic marks at the examined regions was quantified relative to the input amount.
Cell proliferation, migration and invasion assay Cell proliferation of HCC lines stably transduced with HCV core protein was examined by 5-bromo-2-deoxyuridine (BrdU) and 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) incorporation assay. 11 In vitro migration and invasion assays were performed using a 24-well Transwell unit with polycarbonate filters (Corning Costar, Cambridge, MA, USA).
Detailed description of the Materials and methods used can be found in the Supplementary file.
Statistical analysis
The data were presented as mean ± s.d. Statistical analysis was performed using the SPSS 15.0 software. The Student's t-test was used for statistical analysis between two groups. Differences between groups were compared by the analysis of variance (ANOVA) test. In all assays, the probability value (P) of o0.05 was considered statistically significant. Error bars represent s.d. of three independent experiments.
